QQ客服 官方微博 反馈留言

	Incidence and risk of severe infections associated with aflibercept in cancer patients: a systematic review and meta-analysis
	Zhang, Xi[1]; Ran, Yuge[2]; Shao, Yongjie[3]; Wang, Kunjie[4]; Zhu, Yuanxue[5]
刊名	BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
	2016
卷号	81期号:1页码:33-40
关键词	aflibercept cancer infections meta-analysis
ISSN号	0306-5251
DOI	http://dx.doi.org/10.1111/bcp.12758
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5065897
专题	河北大学
作者单位	1.[1]Hebei Univ, Dept Radiat Oncol, Affiliated Hosp, Baoding 071000, Hebei, Peoples R China. 2.[2]Hebei Univ, Dept Radiat Oncol, Affiliated Hosp, Baoding 071000, Hebei, Peoples R China. 3.[3]Hebei Univ, Dept Intervent, Affiliated Hosp, Baoding 071000, Hebei, Peoples R China. 4.[4]Hebei Univ, Dept Med Oncol, Affiliated Hosp, Baoding 071000, Hebei, Peoples R China. 5.[5]Hebei Univ, Dept Med Oncol, Affiliated Hosp, Baoding 071000, Hebei, Peoples R China.
推荐引用方式 GB/T 7714	Zhang, Xi[1],Ran, Yuge[2],Shao, Yongjie[3],et al. Incidence and risk of severe infections associated with aflibercept in cancer patients: a systematic review and meta-analysis[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY,2016,81(1):33-40.
APA	Zhang, Xi[1],Ran, Yuge[2],Shao, Yongjie[3],Wang, Kunjie[4],&Zhu, Yuanxue[5].(2016).Incidence and risk of severe infections associated with aflibercept in cancer patients: a systematic review and meta-analysis.BRITISH JOURNAL OF CLINICAL PHARMACOLOGY,81(1),33-40.
MLA	Zhang, Xi[1],et al."Incidence and risk of severe infections associated with aflibercept in cancer patients: a systematic review and meta-analysis".BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 81.1(2016):33-40.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。